Christian Medial Fellowship
Printed from:
CMF on Facebook CMF on Twitter CMF on YouTube RSS Get in Touch with CMF
menu advocacy

current consultations

Consultation responses

CMF regularly makes submissions to Government and other consultations on issues of ethical importance. All of our submissions are accessible here, along with some briefing notes from us or trusted others to help you think through the issues involved. If you're unsure how to complete a consultation, this Quick Guide should help you get started.

Scottish Government consultation: Delivery of relationships, sexual health, and parenthood (RSHP) education in Scottish schools - draft statutory guidance

Read the consultation document

Consultation closed on 23 November 2023

Department of Education in NI: Relationships and Sexuality Education (RSE) Consultation

Read the consultation documents

Consultation closed on Friday 24 November 2023

CMF has submitted responses to both these consultations. Submissions can be found via:

NHS England: Interim Clinical Policy: Puberty suppressing hormones for children and adolescents who have gender incongruence/dysphoria

This consultation is to seek views on a proposed interim clinical policy on puberty suppressing hormones (sometimes referred to as 'puberty blockers' or 'hormone blockers') for children and adolescents who have early onset gender incongruence or dysphoria. The policy proposition is that puberty suppressing hormones are not recommended to be available as a routine commissioning option.

Consultation documents can be found here.

A guideline document is available here, and the online response form here.

The consultation period ends on 1 November 2023

Christian Medical Fellowship:
uniting & equipping Christian doctors & nurses
Contact Phone020 7234 9660
Contact Address6 Marshalsea Road, London SE1 1HL
© 2023 Christian Medical Fellowship. A company limited by guarantee.
Registered in England no. 6949436. Registered Charity no. 1131658.
Design: S2 Design & Advertising Ltd   
Technical: ctrlcube.